Growth plates status

[Sardartalal]

I am 17 and 5'6 just got the x-rays am I cooked

 

[futureschizo]

yes you're cooked.

 

[LS2019]

Time for LL

 

[truehms]

yea ur wrist plate is closed im sorry bro

http://vl.academicdirect.ro/medical_informatics/bone_age/v1.0/ use this

 

[i cant lie cant lie]

oVer

 

[Zagro]

I am 17 and 5'6 just got the x-rays am I cooked

Looks open

 

[wheyfart]

Not over but gains might be negligible
AI and HGH asap

 

[trenmaxer]

I am 17 and 5'6 just got the x-rays am I cooked

Thats actually pretty open ngl especially. Knees

 

[trenmaxer]

I am 17 and 5'6 just got the x-rays am I cooked

When did u take the xray?

 

[cam1000]

Not over but gains might be negligible
AI and HGH asap

yes good idea, inhibit estrogen during puberty and become retarded for maybe 1 cm

 

[wheyfart]

yes good idea, inhibit estrogen during puberty and become retarded for maybe 1 cm

”become retarded”
Holy cope
Just say you’re too retarded to do bloods

 

[cam1000]

”become retarded”
Holy cope
Just say you’re too retarded to do bloods

Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature - PMC

Growth of short children in puberty is limited by the effect of estrogen on epiphyseal fusion. To compare: 1) the efficacy and safety of aromatase inhibitors (AIs) vs GH vs AI/GH on increasing adult height potential in pubertal boys with severe ...

pmc.ncbi.nlm.nih.gov

you're coping nigger. Such a negligible difference for something most people lack the capacity to properly execute.

All patients grew during the initial 24 months of treatment; hence, all within-group changes are highly significant (between-group comparisons are shown in parentheses): mean change (SE)—AI, +14.0 (0.8) cm; GH, +17.1 (0.9) cm; AI/GH, +18.9 (0.8) cm (P < .0006 between groups) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.). The expected height gain in boys with height SDS of −2.0 is +10.1 cm in the same age period (25). At 36 months, those who continued treatments grew more (between 24 and 36 months) than those who discontinued: continued—AI, +4.9 (1.0) cm; GH, +6.8 (0.4) cm; AI/GH, +7.8 (0.5) cm (P = .032) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.); discontinued—AI, +4.1 (1.1) cm; GH, +2.1 (0.6) cm; AI/GH, 3.0 (0.5) cm (P = .103) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.) (P = < .001) [P value of overall difference in mean changes (from 24 mo to 36 mo) between continued and discontinued group]. Mean absolute height SDS in all three groups was comparable at baseline (−2.2 to −2.4 SDS) and improved at 24 months: AI, −1.73 (0.12) SDS; GH, −1.43 (0.14) SDS; AI/GH, −1.25 (0.12) SDS (P < .0012) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.) (Figure 1A). The change in bone age in 24 months from baseline was: AI, +2.1 (0.3) years; GH, +2.5 (0.1) years; AI/GH, +1.9 (0.2) years (P = .002) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.), larger change for the GH group (Figure 1B). Height SDS adjusted for bone age at 24 months was: AI, −1.06 (0.14); GH, −1.11 (0.20); AI/GH, −0.41 (0.13) (P = .0002) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.).

Not to mention, mean age of 14.1, anyways whatever helps you feel better.

 

[trenmaxer]

Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature - PMC

Growth of short children in puberty is limited by the effect of estrogen on epiphyseal fusion. To compare: 1) the efficacy and safety of aromatase inhibitors (AIs) vs GH vs AI/GH on increasing adult height potential in pubertal boys with severe ...

pmc.ncbi.nlm.nih.gov

you're coping nigger. Such a negligible difference for something most people lack the capacity to properly execute.

All patients grew during the initial 24 months of treatment; hence, all within-group changes are highly significant (between-group comparisons are shown in parentheses): mean change (SE)—AI, +14.0 (0.8) cm; GH, +17.1 (0.9) cm; AI/GH, +18.9 (0.8) cm (P < .0006 between groups) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.). The expected height gain in boys with height SDS of −2.0 is +10.1 cm in the same age period (25). At 36 months, those who continued treatments grew more (between 24 and 36 months) than those who discontinued: continued—AI, +4.9 (1.0) cm; GH, +6.8 (0.4) cm; AI/GH, +7.8 (0.5) cm (P = .032) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.); discontinued—AI, +4.1 (1.1) cm; GH, +2.1 (0.6) cm; AI/GH, 3.0 (0.5) cm (P = .103) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.) (P = < .001) [P value of overall difference in mean changes (from 24 mo to 36 mo) between continued and discontinued group]. Mean absolute height SDS in all three groups was comparable at baseline (−2.2 to −2.4 SDS) and improved at 24 months: AI, −1.73 (0.12) SDS; GH, −1.43 (0.14) SDS; AI/GH, −1.25 (0.12) SDS (P < .0012) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.) (Figure 1A). The change in bone age in 24 months from baseline was: AI, +2.1 (0.3) years; GH, +2.5 (0.1) years; AI/GH, +1.9 (0.2) years (P = .002) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.), larger change for the GH group (Figure 1B). Height SDS adjusted for bone age at 24 months was: AI, −1.06 (0.14); GH, −1.11 (0.20); AI/GH, −0.41 (0.13) (P = .0002) (P value represents the probability of difference in mean changes between groups for all parameters. ANCOVA was used and model adjusted for baseline height.).

Not to mention, mean age of 14.1, anyways whatever helps you feel better.

I grew at 17 from hgh

 

[cam1000]

I grew at 17 from hgh

Likely would’ve happened anyways

 

[nezobot]

17 5'6 ggs